Cargando…
Myeloid sarcoma: more and less than a distinct entity
Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour mass of myeloid blasts occurring at an anatomical site other than the bone marrow, in most cases concomitant with acute myeloid leukaemia (AML), rarely without bone marrow involvement. MS may also represent the bla...
Autores principales: | Loscocco, Giuseppe G., Vannucchi, Alessandro M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345021/ https://www.ncbi.nlm.nih.gov/pubmed/37286874 http://dx.doi.org/10.1007/s00277-023-05288-1 |
Ejemplares similares
-
Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data
por: Loscocco, Giuseppe G, et al.
Publicado: (2020) -
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms
por: Loscocco, Giuseppe G., et al.
Publicado: (2021) -
Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology
por: Zorn, Kristin E., et al.
Publicado: (2023) -
Bacterial Toxin–Antitoxin Systems: More Than Selfish Entities?
por: Van Melderen, Laurence, et al.
Publicado: (2009) -
Oral Potentially Malignant Disorders: An Overview of More than 20 Entities
por: Mortazavi, Hamed, et al.
Publicado: (2014)